SI1189600T1 - Grf-containing lyophilized pharmaceutical compositions - Google Patents

Grf-containing lyophilized pharmaceutical compositions

Info

Publication number
SI1189600T1
SI1189600T1 SI200030199T SI200030199T SI1189600T1 SI 1189600 T1 SI1189600 T1 SI 1189600T1 SI 200030199 T SI200030199 T SI 200030199T SI 200030199 T SI200030199 T SI 200030199T SI 1189600 T1 SI1189600 T1 SI 1189600T1
Authority
SI
Slovenia
Prior art keywords
grf
pharmaceutical compositions
lyophilized pharmaceutical
containing lyophilized
compositions
Prior art date
Application number
SI200030199T
Other languages
English (en)
Slovenian (sl)
Inventor
Fabrizio Samaritani
Rio Alessandra Del
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of SI1189600T1 publication Critical patent/SI1189600T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI200030199T 1999-06-30 2000-06-29 Grf-containing lyophilized pharmaceutical compositions SI1189600T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99112421A EP1064934A1 (en) 1999-06-30 1999-06-30 GRF-containing lyophilized pharmaceutical composition
EP00949226A EP1189600B1 (en) 1999-06-30 2000-06-29 Grf-containing lyophilized pharmaceutical compositions
PCT/EP2000/006061 WO2001001965A1 (en) 1999-06-30 2000-06-29 Grf-containing lyophilized pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SI1189600T1 true SI1189600T1 (en) 2003-12-31

Family

ID=8238452

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030199T SI1189600T1 (en) 1999-06-30 2000-06-29 Grf-containing lyophilized pharmaceutical compositions

Country Status (14)

Country Link
US (2) US20060160739A1 (ja)
EP (2) EP1064934A1 (ja)
JP (1) JP4880845B2 (ja)
AR (1) AR024613A1 (ja)
AT (1) ATE249207T1 (ja)
AU (1) AU778208C (ja)
CA (1) CA2374933C (ja)
DE (1) DE60005188T2 (ja)
DK (1) DK1189600T3 (ja)
ES (1) ES2204661T3 (ja)
IL (2) IL147413A0 (ja)
PT (1) PT1189600E (ja)
SI (1) SI1189600T1 (ja)
WO (1) WO2001001965A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1301200A2 (en) * 2000-05-19 2003-04-16 Bionebraska, Inc. Peptide pharmaceutical formulations
MXPA05002991A (es) * 2002-09-18 2005-10-05 Univ Montreal Ct Hospitalier Chum Analogos de ghrh.
EP2142207A4 (en) * 2007-04-04 2013-01-16 Theratechnologies Inc PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
TWI441915B (zh) * 2007-09-07 2014-06-21 Nisshin Oillio Group Ltd １，３－二飽和－２－不飽和三酸甘油酯的區分方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822445B2 (ja) * 1982-07-08 1983-05-09 株式会社 ミドリ十字 安定な固体の人血漿コリンエステラ−ゼ製剤の製法
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
EP0189673B1 (en) * 1984-12-24 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Stable growth hormone releasing factor preparation
JPH0725696B2 (ja) * 1986-05-29 1995-03-22 株式会社ミドリ十字 プラスミノ−ゲンの安定化方法
US5017557A (en) * 1987-07-24 1991-05-21 Industria Farmaceutica Serono S.P.A. Treatment of infertility with somatotrophin releasing factor
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
WO1990011070A1 (en) * 1989-03-17 1990-10-04 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
JPH0383931A (ja) * 1989-08-29 1991-04-09 Sumitomo Pharmaceut Co Ltd 低刺激性ｇｒｆ経鼻投与製剤
US5132401A (en) * 1989-09-19 1992-07-21 George Washington University, Office Of Sponsored Research MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary
JPH04264020A (ja) * 1991-02-18 1992-09-18 Yamanouchi Pharmaceut Co Ltd 安定な凍結乾燥製剤
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
JP3140797B2 (ja) * 1991-04-26 2001-03-05 生化学工業株式会社 安定化コンドロイチナーゼａｂｃ、その保存方法及び治療剤
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
JP3083931B2 (ja) 1993-02-24 2000-09-04 大阪瓦斯株式会社 吸収式冷凍機の故障診断システム
IS1796B (is) 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
DE69420872T2 (de) 1994-06-17 2000-01-13 Applied Research Systems Hgh enthaltende pharmazeutische zubereitungen
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
CA2226575C (en) * 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
EP0880969A1 (en) * 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Pharmaceutical compositions of peptides having low solubility in physiological medium
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
US6759393B1 (en) * 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
JP4330280B2 (ja) 2001-01-12 2009-09-16 株式会社小松製作所 エンジンの燃料噴射制御方法及びその制御装置

Also Published As

Publication number Publication date
CA2374933C (en) 2010-10-12
AU6266300A (en) 2001-01-22
DE60005188T2 (de) 2004-04-01
DK1189600T3 (da) 2004-01-26
AR024613A1 (es) 2002-10-16
JP2003503443A (ja) 2003-01-28
US20070203069A1 (en) 2007-08-30
WO2001001965A1 (en) 2001-01-11
IL147413A (en) 2006-10-31
US20060160739A1 (en) 2006-07-20
AU778208B2 (en) 2004-11-25
ATE249207T1 (de) 2003-09-15
IL147413A0 (en) 2002-08-14
PT1189600E (pt) 2003-12-31
EP1189600B1 (en) 2003-09-10
DE60005188D1 (de) 2003-10-16
CA2374933A1 (en) 2001-01-11
EP1189600A1 (en) 2002-03-27
JP4880845B2 (ja) 2012-02-22
AU778208C (en) 2006-03-09
ES2204661T3 (es) 2004-05-01
US8431534B2 (en) 2013-04-30
EP1064934A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
PL351387A1 (en) Pharmaceutical composition
HU9901606D0 (en) Pharmaceutical compositions
HK1044476A1 (en) Medicinal compositions
GB9827996D0 (en) Pharmaceutical Compositions
GB9923436D0 (en) Pharmaceutical compositions
HUP0201372A3 (en) Pharmaceutical compositions comprising cyclosporin
AU3556400A (en) Pharmaceutical compositions
EP1166786A4 (en) MEDICAL COMPOSITIONS
GB9904163D0 (en) Pharmaceutical compositions
GB9809213D0 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU6460200A (en) Pharmaceutical compositions
GB9802472D0 (en) Pharmaceutical compositions
GB9904911D0 (en) Pharmaceutical compositions
SI1189600T1 (en) Grf-containing lyophilized pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
IL130325A0 (en) Pharmaceutical compositions comprising allicin
GB9902651D0 (en) Pharmaceutical compositions
GB9806487D0 (en) Pharmaceutical compositions
GB9902594D0 (en) Pharmaceutical compositions
GB9902591D0 (en) Pharmaceutical compositions
GB9920652D0 (en) Pharmaceutical compositions